NCCN 2013 Biomarkers Congress Webinar Series: So the Test is Approved…Why Should I Use It?

March 26, 2013

Biomarkers now play a key role in the routine management of patients with cancer and guide drug development in the age of targeted therapy.This webinar series will address the demand for reliable, practical information about biomarkers and their appropriate use, biomarker testing, application of test results, and clinical utility of biomarkers.

 

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Explain the significance of FDA approval as it applies to a diagnostic test
  • Provide examples of marketed molecular tests that do and do not meet the standards of clinical usefulness
Additional information
Supporters: 

This activity is supported by educational grants from Abbott; Astellas Scientific and Medical Affairs, Inc.; Genentech; Novartis Pharmaceuticals Corporation; and Veridex, LLC.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
03/26/2013
Course expires: 
06/07/2013
Event starts: 
03/26/2013 - 12:00pm EDT
Event ends: 
03/26/2013 - 1:00pm EDT
Cost:
$0.00
Add to calendar: 

Christine Lovly, MD, PhD
Vanderbilt-Ingram Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.